Finance Paid
Pure Biologics reveals Phase 0 results
20:21
Pure Biologics has reported initial results from its Phase 0 study of PB004 (PBA-0405), involving three patients with various solid tumors. The ongoing study aims to assess PBA-0405's efficacy in targeting cancer cells in conditions such as head and neck cancer, soft tissue sarcoma…
This article is for subscribers
Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.
SubscribeOr try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.
